The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study DOI Open Access
Ioannis Katsaros, Maria Sotiropoulou, Michail Vailas

и другие.

Nutrients, Год журнала: 2024, Номер 16(24), С. 4282 - 4282

Опубликована: Дек. 11, 2024

Background/Objectives: Non-alcoholic fatty liver disease (NAFLD) is a major metabolic disorder with no established pharmacotherapy. Quercetin, polyphenolic flavonoid, demonstrates potential hepatoprotective effects but has limited bioavailability. This study evaluates the impact of quercetin on NAFLD and assesses roles autophagy-related proteins in progression. Methods: Forty-seven male C57BL/6J mice were fed high-fat diet (HFD) for 12 weeks to induce NAFLD, followed by treatment 4 weeks. Mice divided into baseline, control, two groups, receiving low (10 mg/kg) high (50 doses. Liver histology was scored using Activity Score (NAS). Immunohistochemistry immunoblotting performed analyze autophagy markers. Results: Quercetin-treated groups showed significant reductions NAS compared controls (p = 0.011), mainly steatosis steatohepatitis. indicated increased expression markers LCA p62 groups. Western blot analysis revealed elevations LC3A treated suggesting improved autophagic activity lipid degradation. Conclusions: Quercetin effectively reduces severity modulates proteins. These findings suggest that enhances flux, supporting its therapeutic NAFLD. Additional research needed clarify molecular mechanisms determine optimal dosing clinical application.

Язык: Английский

Totum-448, a polyphenol-rich plant extract, decreases hepatic steatosis and inflammation in diet-induced MASLD mice DOI
Joost M. Lambooij, Vivien Chavanelle, Marie Vallier

и другие.

Research Square (Research Square), Год журнала: 2025, Номер unknown

Опубликована: Апрель 7, 2025

Abstract The increasing prevalence of obesity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) urges the development new therapeutic strategies. Totum-448 is a unique patented combination polyphenol-rich plant extracts designed to reduce hepatic steatosis, risk factor for steatohepatitis and type 2 diabetes. In this study, we investigated effects on homeostasis in diet-induced MASLD mice. For purpose, male C57Bl6/J mice were fed high-fat diet with sucrose-containing drinking water 12 weeks, followed by supplementation or without 4 weeks. Body weight/composition, caloric intake, plasma parameters whole-body glucose tolerance measured throughout study fecal microbiota composition was determined 16S sequencing. Hepatic transcriptomic/lipidomic profiles immune cell assessed histological/biochemical assays, RNA sequencing, MS-based lipidomics, spectral flow cytometry. We found that significantly lowered hyperinsulinemia systemic intolerance affecting body weight, fat mass, calorie feces production composition. Furthermore, decrease activity score macrovesicular triglycerides cholesterol contents, alanine aminotransferase levels observed. also reduced inflammatory pro-fibrotic transcriptomic signatures decreased both MASLD-induced loss tissue-resident Kupffer cells recruitment monocyte-derived pro-inflammatory macrophages. Altogether, reduces steatosis inflammation insulin-resistant, steatotic, obese mice, dual effect likely contributes improved homeostasis. Supplementation may therefore constitute promising novel nutritional approach patients.

Язык: Английский

Процитировано

0

Interaction of starch nanoparticles with digestive enzymes and its effect on the release of polyphenols in simulated gastrointestinal fluids DOI
Jie Yang, Yujing Sun, Xuyan Dong

и другие.

Food Chemistry, Год журнала: 2025, Номер 472, С. 142883 - 142883

Опубликована: Янв. 11, 2025

Язык: Английский

Процитировано

0

Hepatoprotective effect of the Sechium HD-Victor hybrid extract in a model of liver damage induced by carbon tetrachloride in mice DOI Open Access
Eliana Vásquez Osorio,

Ramírez-Padilla María-Guadalupe,

Mendoza-Núñez Víctor-Manuel

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2025, Номер 183, С. 117831 - 117831

Опубликована: Янв. 22, 2025

Язык: Английский

Процитировано

0

Effects of polyphenols on non-alcoholic fatty liver disease: a case study of resveratrol DOI
Ying Zhao, Jiali Ren, Weisan Chen

и другие.

Food & Function, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Plant polyphenols show good potential for preventing chronic metabolic diseases, especially resveratrol, by reducing insulin resistance and fat synthesis linked to non-alcoholic fatty liver disease.

Язык: Английский

Процитировано

0

The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study DOI Open Access
Ioannis Katsaros, Maria Sotiropoulou, Michail Vailas

и другие.

Nutrients, Год журнала: 2024, Номер 16(24), С. 4282 - 4282

Опубликована: Дек. 11, 2024

Background/Objectives: Non-alcoholic fatty liver disease (NAFLD) is a major metabolic disorder with no established pharmacotherapy. Quercetin, polyphenolic flavonoid, demonstrates potential hepatoprotective effects but has limited bioavailability. This study evaluates the impact of quercetin on NAFLD and assesses roles autophagy-related proteins in progression. Methods: Forty-seven male C57BL/6J mice were fed high-fat diet (HFD) for 12 weeks to induce NAFLD, followed by treatment 4 weeks. Mice divided into baseline, control, two groups, receiving low (10 mg/kg) high (50 doses. Liver histology was scored using Activity Score (NAS). Immunohistochemistry immunoblotting performed analyze autophagy markers. Results: Quercetin-treated groups showed significant reductions NAS compared controls (p = 0.011), mainly steatosis steatohepatitis. indicated increased expression markers LCA p62 groups. Western blot analysis revealed elevations LC3A treated suggesting improved autophagic activity lipid degradation. Conclusions: Quercetin effectively reduces severity modulates proteins. These findings suggest that enhances flux, supporting its therapeutic NAFLD. Additional research needed clarify molecular mechanisms determine optimal dosing clinical application.

Язык: Английский

Процитировано

0